Compare MRM & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRM | AIMD |
|---|---|---|
| Founded | 2000 | 1984 |
| Country | Japan | United States |
| Employees | N/A | 44 |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.0M | 9.8M |
| IPO Year | 2020 | N/A |
| Metric | MRM | AIMD |
|---|---|---|
| Price | $1.17 | $1.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 174.4K | 26.9K |
| Earning Date | 05-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $32.01 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $0.44 |
| 52 Week High | $4.45 | $4.50 |
| Indicator | MRM | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 26.37 | 46.00 |
| Support Level | $1.10 | $1.33 |
| Resistance Level | $1.64 | $1.73 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 8.59 | 37.14 |
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.